Offsets |
Jul. 28, 2026
USD ($)
|
|---|---|
| Offset: 1 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | Neurosense Therapeutics Ltd. |
| Form or Filing Type | F-3 |
| File Number | 333-269306 |
| Initial Filing Date | Jan. 19, 2023 |
| Fee Offset Claimed | $ 9,290.00 |
| Security Type Associated with Fee Offset Claimed | Equity |
| Security Title Associated with Fee Offset Claimed | Common Stock, Warrants and Units |
| Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | $ 84,305,818.00 |
| Termination / Withdrawal Statement | Pursuant to Rule 415(a)(6) under the Securities Act, the securities registered pursuant to this registration statement include $84,305,818 of unsold securities (the “Unsold Securities”) previously registered and offered by the registrant pursuant to the Registration Statement on Form F-3 (File No. 333-269306) (the “Prior Registration Statement”), which was declared effective on January 30, 2023. In connection with the filing of the Prior Registration Statement, the registrant paid a filing fee of $11,020 with respect to an aggregate of $100,000,000 of securities, of which $9,290 relates to the Unsold Securities (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement). Following the initial filing of this registration statement on January 30, 2026 and prior to the filing of this Amendment No. 1, the Registrant sold securities having an aggregate offering amount of $1,472,248 pursuant to the Prior Registration Statement. Accordingly, the amount of Unsold Securities eligible to be carried forward pursuant to Rule 415(a)(6) has been reduced from $85,778,066 to $84,305,818, and the fee offset claimed pursuant to Rule 457(p) has been adjusted accordingly. Pursuant to Rule 457(p), the filing fee associated with such Unsold Securities is hereby carried forward and applied to the securities registered under this registration statement. |
| Offset: 2 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(p) Offset | true |
| Registrant or Filer Name | Neurosense Therapeutics Ltd. |
| Form or Filing Type | F-3 |
| File Number | 333-269306 |
| Filing Date | Jan. 19, 2023 |
| Fee Paid with Fee Offset Source | $ 9,290.00 |